Cargando…
Comparison between an SGLT2 inhibitor and insulin in tumor-to-tissue contrasts in (18)F-FDG PET imaging of diabetic mice
(18)F-fluorodeoxyglucose positron emission tomography ((18)F-FDG PET) has been widely utilized for tumor diagnosis. Hyperglycemia affects the (18)F-FDG uptake and reduces tumor-to-tissue contrasts, however, ideal hypoglycemic drugs are lacking. This study compared the role of insulin with the novel...
Autores principales: | Meidai, Liang, Yujing, Du, Zhaoyu, Liu, Shanshi, Li, Guangyu, Zhao, Yan, Fan, Xiuying, Yang, Jianhua, Zhang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10603037/ https://www.ncbi.nlm.nih.gov/pubmed/37884546 http://dx.doi.org/10.1038/s41598-023-45094-3 |
Ejemplares similares
-
Response evaluation of SGLT2 inhibitor therapy in patients with type 2 diabetes mellitus using (18)F-FDG PET/MRI
por: Rasul, Sazan, et al.
Publicado: (2020) -
The value on SUV-derived parameters assessed on (18)F-FDG PET/CT for predicting mediastinal lymph node metastasis in non-small cell lung cancer
por: Liao, Xuhe, et al.
Publicado: (2023) -
Tracer‐specific reference tissues selection improves detection of
(18)F‐FDG,
(18)F‐florbetapir, and
(18)F‐flortaucipir PET SUVR changes in Alzheimer's disease
por: Li, Yanxiao, et al.
Publicado: (2022) -
PET probes beyond (18)F-FDG
por: Jiang, Lei, et al.
Publicado: (2014) -
Measurement Repeatability of (18)F-FDG PET/CT Versus (18)F-FDG PET/MRI in Solid Tumors of the Pelvis
por: Fraum, Tyler J., et al.
Publicado: (2019)